Andreas Kimergård

1.0k total citations
30 papers, 652 citations indexed

About

Andreas Kimergård is a scholar working on Toxicology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Andreas Kimergård has authored 30 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Toxicology, 10 papers in Epidemiology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Andreas Kimergård's work include Opioid Use Disorder Treatment (10 papers), Forensic Toxicology and Drug Analysis (10 papers) and Hormonal and reproductive studies (7 papers). Andreas Kimergård is often cited by papers focused on Opioid Use Disorder Treatment (10 papers), Forensic Toxicology and Drug Analysis (10 papers) and Hormonal and reproductive studies (7 papers). Andreas Kimergård collaborates with scholars based in United Kingdom, Denmark and Ireland. Andreas Kimergård's co-authors include Jim McVeigh, Paolo Deluca, Michael Evans‐Brown, Colin Drummond, Torben Breindahl, Vivian Hope, Fortune Ncube, Andrea Marongiu, Mette Findal Andreasen and Daniel Sejer Pedersen and has published in prestigious journals such as Addiction, BMC Public Health and BMJ Open.

In The Last Decade

Andreas Kimergård

30 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Kimergård United Kingdom 15 266 192 136 123 114 30 652
Ingrid Amalia Havnes Norway 14 256 1.0× 177 0.9× 240 1.8× 219 1.8× 57 0.5× 41 693
Katinka van de Ven Australia 17 245 0.9× 295 1.5× 159 1.2× 120 1.0× 30 0.3× 38 695
Robert Ralphs United Kingdom 13 62 0.2× 296 1.5× 145 1.1× 39 0.3× 110 1.0× 34 557
Evelyn Hearne United Kingdom 12 63 0.2× 83 0.4× 103 0.8× 63 0.5× 141 1.2× 29 365
Tom Mieczkowski United States 19 68 0.3× 446 2.3× 217 1.6× 42 0.3× 334 2.9× 47 1.1k
Cheneal Puljević Australia 12 40 0.2× 138 0.7× 164 1.2× 53 0.4× 23 0.2× 81 571
Carolyn Seymore Ashworth United States 12 203 0.8× 85 0.4× 101 0.7× 61 0.5× 7 0.1× 18 597
Patrick Laure France 13 361 1.4× 438 2.3× 34 0.3× 30 0.2× 17 0.1× 55 629
Mas Ayu Said Malaysia 16 49 0.2× 68 0.4× 98 0.7× 123 1.0× 18 0.2× 42 694
Johanna Gripenberg Sweden 14 35 0.1× 88 0.5× 405 3.0× 89 0.7× 56 0.5× 45 661

Countries citing papers authored by Andreas Kimergård

Since Specialization
Citations

This map shows the geographic impact of Andreas Kimergård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Kimergård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Kimergård more than expected).

Fields of papers citing papers by Andreas Kimergård

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Kimergård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Kimergård. The network helps show where Andreas Kimergård may publish in the future.

Co-authorship network of co-authors of Andreas Kimergård

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Kimergård. A scholar is included among the top collaborators of Andreas Kimergård based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Kimergård. Andreas Kimergård is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kimergård, Andreas, et al.. (2022). Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysis. BMJ Open. 12(7). e056445–e056445. 23 indexed citations
2.
3.
Kimergård, Andreas, Zarnie Khadjesari, Simon Coulton, et al.. (2020). Assertive outreach treatment versus care as usual for the treatment of high-need, high-cost alcohol related frequent attenders: study protocol for a randomised controlled trial. BMC Public Health. 20(1). 332–332. 5 indexed citations
4.
Kimergård, Andreas, et al.. (2020). Identification of factors influencing tampering of codeine-containing medicines in England: a qualitative study. Harm Reduction Journal. 17(1). 63–63. 3 indexed citations
5.
Breindahl, Torben, Peter Hindersson, & Andreas Kimergård. (2020). New psychoactive substances (NPS) escape routine drug testing: a case report of phenibut. VBN Forskningsportal (Aalborg Universitet). 4(1). 55–58. 5 indexed citations
6.
Kinnaird, Emma, Andreas Kimergård, Stacey Jennings, Colin Drummond, & Paolo Deluca. (2019). From pain treatment to opioid dependence: a qualitative study of the environmental influence on codeine use in UK adults. BMJ Open. 9(4). e025331–e025331. 14 indexed citations
7.
Milward, Joanna, Paolo Deluca, Colin Drummond, & Andreas Kimergård. (2018). Developing Typologies of User Engagement With the BRANCH Alcohol-Harm Reduction Smartphone App: Qualitative Study. JMIR mhealth and uhealth. 6(12). e11692–e11692. 29 indexed citations
8.
Kimergård, Andreas, Jamie Brown, Emma Beard, et al.. (2018). Attempts to reduce alcohol intake and treatment needs among people with probable alcohol dependence in England: a general population survey. Addiction. 113(8). 1430–1438. 14 indexed citations
9.
Deluca, Paolo, et al.. (2018). Advertising of Over-the-Counter Codeine-Containing Medicines in the EU: Differences in the Regulation of Advertising Between Member States. Pharmaceutical Medicine. 32(5). 327–333. 5 indexed citations
10.
11.
Milward, Joanna, et al.. (2017). Usability Testing of the BRANCH Smartphone App Designed to Reduce Harmful Drinking in Young Adults. JMIR mhealth and uhealth. 5(8). e109–e109. 30 indexed citations
12.
Kimergård, Andreas, et al.. (2017). Codeine use, dependence and help-seeking behaviour in the UK and Ireland: an online cross-sectional survey. QJM. 110(9). 559–564. 25 indexed citations
13.
Kimergård, Andreas, et al.. (2017). A National Survey of Assertive Outreach Treatment Services for People Who Frequently Attend Hospital due to Alcohol-Related Reasons in England. Alcohol and Alcoholism. 53(3). 277–281. 4 indexed citations
14.
Kimergård, Andreas, Paolo Deluca, Peter Hindersson, & Torben Breindahl. (2016). How Resistant to Tampering are Codeine Containing Analgesics on the Market? Assessing the Potential for Opioid Extraction. Pain and Therapy. 5(2). 187–201. 8 indexed citations
15.
16.
Kimergård, Andreas & Jim McVeigh. (2014). Variability and dilemmas in harm reduction for anabolic steroid users in the UK: a multi-area interview study. Harm Reduction Journal. 11(1). 19–19. 65 indexed citations
17.
Kimergård, Andreas. (2014). A qualitative study of anabolic steroid use amongst gym users in the United Kingdom: motives, beliefs and experiences. Journal of Substance Use. 20(4). 288–294. 76 indexed citations
18.
Hope, Vivian, Jim McVeigh, Andrea Marongiu, et al.. (2014). Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking. Epidemiology and Infection. 143(1). 132–140. 44 indexed citations
19.
Hope, Vivian, Jim McVeigh, Andrea Marongiu, et al.. (2013). Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study. BMJ Open. 3(9). e003207–e003207. 90 indexed citations
20.
Evans‐Brown, Michael, Andreas Kimergård, & Jim McVeigh. (2009). Elephant in the room? The methodological implications for public health research of performance‐enhancing drugs derived from the illicit market. Drug Testing and Analysis. 1(7). 323–326. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingrid Amalia Havnes Breakdown of academic impact, for papers by Katinka van de Ven Breakdown of academic impact, for papers by Robert Ralphs Breakdown of academic impact, for papers by Evelyn Hearne Breakdown of academic impact, for papers by Tom Mieczkowski Breakdown of academic impact, for papers by Cheneal Puljević Breakdown of academic impact, for papers by Carolyn Seymore Ashworth Breakdown of academic impact, for papers by Patrick Laure Breakdown of academic impact, for papers by Mas Ayu Said Breakdown of academic impact, for papers by Johanna Gripenberg
Rankless by CCL
2026